{"nct_id":"NCT02014480","title":"A Cross-Over Study to Evaluate Lung Function Response After Treatment With Umeclidinium (UMEC) 62.5 Micrograms (mcg), Vilanterol (VI) 25 mcg, and Umeclidinium/Vilanterol (UMEC/VI) 62.5/25 mcg Once-Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","status_verified_date":"2018-01","start_date":"2013-02-01","start_date_type":null,"primary_completion_date":"2013-06-01","primary_completion_date_type":"ACTUAL","completion_date":"2013-06-11","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}